| AGE | advanced glycation end-product |
| AGEs | advanced glycation end-products |
| CAN | cardiovascular autonomic neuropathy |
| CML | Nε-carboxymethyllysine |
| CRP | C-reactive protein |
| DIAPH1 | diaphanous-related formin 1 |
| EGCG | epigallocatechin gallate |
| FMNL1 | formin-like protein 1 |
| GLP-1 | glucagon-like peptide-1 |
| GPX-4 | glutathione peroxidase 4 |
| GSK3β | glycogen synthase kinase 3 beta |
| HMGB1 | high-mobility group box 1 |
| HO-1 | heme oxygenase 1 |
| HRV | heart rate variability |
| hs-cTnT | high-sensitivity cardiac troponin T |
| IL-6 | interleukin-6 |
| MGO | methylglyoxal |
| NF-κB | nuclear factor kappa B |
| NO | nitric oxide |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| NT-proBNP | N-terminal pro-B-type natriuretic peptide |
| RAGE | receptor for advanced glycation end-products |
| ROS | reactive oxygen species |
| STZ | streptozotocin |
| T2DM | type 2 diabetes mellitus |
| TGF-β | transforming growth factor beta |
| VEGF | vascular endothelial growth factor |